Month: August 2021

All amounts in U.S. dollars unless otherwise stated TORONTO, Aug. 18, 2021 (GLOBE NEWSWIRE) — Onex Corporation (“Onex”) (TSX: ONEX) today announced Onex Partners III (the “Fund”) and certain co-investors, including Onex (together the “Onex Group”), have completed the sale of their remaining approximately 14.9 million shares of JELD-WEN Holding, Inc. (“JELD-WEN”) (NYSE: JELD) common stock at a net price of $28.50 per share. JELD-WEN is one of the world’s largest door and window manufacturers. With this sale, the Onex Group no longer holds any shares of JELD-WEN. Gross proceeds to the Onex Group from this transaction are approximately $425 million, of which Onex’ share was approximately $110 million as a Limited Partner in the Fund and as a co-investor. On March 1, 2021, a registration statement including a prospectus (File...

BILLERICA, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS) today announced the first procedure with the new Conformis Identity Imprint knee replacement system. Identity Imprint, available in both cruciate retaining (CR) and posterior stabilized (PS) implants, utilizes a proprietary algorithm to select the implant size that most closely meets the geometric and anatomic requirements of the patient’s knee based on the individual’s CT scan. As with Conformis’ personalized iTotal® knee product line, Identity Imprint uses Conformis’ sterile Surgery-in-a-Box™ delivery system, which provides ambulatory surgical centers (ASCs) and hospitals greater procedural efficiency and improved sterilization cost savings over comparable systems. The first surgery was successfully performed by Dr. Moby Parsons at Stratham Ambulatory...

WILMINGTON, Del., Aug. 18, 2021 (GLOBE NEWSWIRE) — Ashland Global Holdings Inc. (NYSE: ASH) announced today that its indirect, wholly owned subsidiary, Ashland LLC, has closed its previously announced offering of $450 million aggregate principal amount of 3.375 percent senior notes due 2031 (the “Notes”). The Notes are senior unsecured obligations of Ashland LLC. The Notes are initially guaranteed on an unsecured basis by Ashland Global Holdings Inc. (the “Guarantee”). Ashland intends to use the net proceeds of the offering, after deducting initial purchasers’ discounts and other fees and expenses, to redeem its obligations under its outstanding 4.750 percent senior notes due 2022, and to pay any premiums, penalties, fees and expenses associated therewith (the “Refinancing”), with any remaining net proceeds to be held as cash...

SAN DIEGO, Aug. 18, 2021 (GLOBE NEWSWIRE) — Genasys Inc. (NASDAQ: GNSS), the global leader in critical communications systems and solutions, today announced Susan Lee and Caltha Seymour have been appointed to the Company’s Board of Directors (Board) effective September 1, 2021. “We welcome Ms. Lee and Ms. Seymour to the Company’s Board,” said Richard Danforth, Chief Executive Officer of Genasys Inc. “They each bring extensive senior executive experience from diverse business backgrounds that will be most beneficial in expanding our worldwide business and increasing shareholder value.” Ms. Lee brings more than 20 years of experience in digital marketing software, media, data analytics, and strategic partnerships to the Board. Lee currently serves as Group President of Digital Marketing & Technology...

CELEBRATION, Fla., Aug. 18, 2021 (GLOBE NEWSWIRE) — KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today the appointment of Tamara A. Seymour to serve on its Board of Directors and as Chair of the Audit Committee. Ms. Seymour brings to KemPharm more than 30 years of life sciences industry experience, including 20 years in the role of chief financial officer. She currently serves as a board member and audit committee chair of Artelo Biosciences, Inc. and Kintara Therapeutics, Inc., both publicly-traded clinical-stage biopharmaceutical companies. “The addition of Tamara to our Board of Directors and her appointment as Chair of the Audit Committee comes at an important phase in the evolution of KemPharm and continues what has been a transformative...